ClinicalTrials.Veeva

Menu

Natural History Study of Batten Disease

E

Emily de los Reyes

Status

Terminated

Conditions

Neuronal Ceroid Lipofuscinosis CLN3
Neuronal Ceroid Lipofuscinosis CLN6
Batten Disease

Study type

Observational

Funder types

Other

Identifiers

NCT04644549
BAT-001

Details and patient eligibility

About

This is a multicenter, international, study to assess the natural history data from people with Batten disease by collecting both retrospective and prospective information about the motor, behavioral and functional capabilities of patients. The study initially has 2 cohorts. Cohort 1 (n ≈ 75) includes subjects with CLN6 Batten disease. Cohort 2 (n ≈ 120) includes subjects with juvenile CLN3 Batten disease. Additional cohorts for other Batten disease subtypes may be added in the future.

Enrollment

10 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Subject has or had a diagnosis of CLN6 or CLN3 Batten disease that has been confirmed by genotyping (documented presence of a variant on both gene alleles). Confirmation of genotyping will be performed prior to enrollment.
  • Subject (or legally authorized representative) has provided written informed consent (or assent) and authorization for use and disclosure of personal health information or research related health information
  • Subjects may enroll starting from birth

Exclusion criteria

  • Subject has or had experienced another illness that is known to cause cognitive decline (eg, trauma, meningitis, hemorrhage)
  • Subject received or receives an investigational gene therapy

Trial design

10 participants in 2 patient groups

Subjects with CLN6 Batten disease
Subjects with juvenile CLN3 Batten disease

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems